|
58
|
257
|
1lhcH |
Human alpha-thrombin complexed with ac-(d)phe-pro-boroarg-oh |
|
55
|
257
|
1lhgH |
Human alpha-thrombin complexed with ac-(d)phe-pro-boroornithine-oh |
|
3
|
26
|
1lheL |
Human alpha-thrombin complexed with ac-(d)phe-pro-boro-n-butyl-amidino-glycine-oh |
|
3
|
26
|
1lhgL |
Human alpha-thrombin complexed with ac-(d)phe-pro-boroornithine-oh |
|
3
|
26
|
1lhfL |
Human alpha-thrombin complexed with ac-(d)phe-pro-boro-homolys-oh |
|
3
|
26
|
1lhcL |
Human alpha-thrombin complexed with ac-(d)phe-pro-boroarg-oh |
|
57
|
257
|
1lhdH |
Human alpha-thrombin complexed with ac-(d)phe-pro-borolys-oh |
|
2
|
27
|
1kttA |
Thrombin inhibitor complex |
|
3
|
27
|
1ktsA |
Thrombin inhibitor complex |
|
61
|
259
|
1kttB |
Thrombin inhibitor complex |
|
61
|
259
|
1ktsB |
Thrombin inhibitor complex |
|
3
|
29
|
1k22L |
Human thrombin-inhibitor complex |
|
2
|
27
|
1k21L |
Human thrombin-inhibitor complex |
|
3
|
29
|
1ihsL |
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 |
|
3
|
47
|
1jmoL |
Crystal structure of the heparin cofactor ii-s195a thrombin complex |
|
57
|
256
|
1k21H |
Human thrombin-inhibitor complex |
|
57
|
258
|
1ihtH |
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 |
|
57
|
259
|
1jouB |
Crystal structure of native s195a thrombin with an unoccupied active site |
|
56
|
258
|
1k22H |
Human thrombin-inhibitor complex |
|
50
|
256
|
1id5H |
Crystal structure of bovine thrombin complex with protease inhibitor ecotin |
|
3
|
29
|
1ihtL |
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 |
|
59
|
256
|
1hxfH |
Human thrombin complex with hirudin variant |
|
2
|
30
|
1id5L |
Crystal structure of bovine thrombin complex with protease inhibitor ecotin |
|
3
|
26
|
1hxfL |
Human thrombin complex with hirudin variant |
|
47
|
256
|
1hltH |
The structure of a nonadecapeptide of the fifth egf domain of thrombomodulin complexed with thrombin |
|
50
|
256
|
1hxeH |
Serine protease |
|
3
|
26
|
1hxeL |
Serine protease |
|
1
|
27
|
1hltJ |
The structure of a nonadecapeptide of the fifth egf domain of thrombomodulin complexed with thrombin |
|
1
|
36
|
1hrtL |
The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8 angstroms resolution |
|
42
|
259
|
1hrtH |
The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8 angstroms resolution |
|
60
|
258
|
1ihsH |
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 |
|
2
|
36
|
1hgtL |
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin |
|
1
|
27
|
1hbtL |
Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor |
|
58
|
259
|
1hahH |
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin |
|
2
|
28
|
1h8dL |
X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. |
|
46
|
259
|
1hdtH |
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin |
|
3
|
36
|
1hahL |
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin |
|
59
|
259
|
1hgtH |
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin |
|
60
|
257
|
1hbtH |
Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor |
|
3
|
33
|
1hdtL |
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin |
|
3
|
36
|
1haiL |
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin |
|
2
|
27
|
1h8iL |
X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. |
|
58
|
253
|
1h8iH |
X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. |
|
58
|
259
|
1haiH |
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin |
|
58
|
295
|
1hagE |
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin |
|
1
|
36
|
1ghxL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
2
|
36
|
1gj5L |
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design |
|
61
|
251
|
1h8dH |
X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. |
|
3
|
36
|
1ghvL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
78
|
305
|
1jwtA |
Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor |
